While the role of GILZ as a key mediator of anti-inflammatory and immunosuppressive GC effects is widely accepted and documented, its ability to mediate tumor cell growth inhibition or promotion has only been hypothesized. The gene discussed is TSC22D3; the disease is neoplasm.